In 2020, there were 2.21 million new cases of lung cancer and 1.8 million deaths from lung cancer worldwide. Approximately 85% of all lung cancers fall under the non–small cell lung cancer (NSCLC) category. Advances in targeted therapies have increased the importance of identifying oncogenic drivers that can act both as therapeutic targets and predictive biomarkers.
How much do you know about molecular and biomarker analysis in NSCLC? Test your knowledge with this quick quiz.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Daniel S. Schwartz, Maurie Markman. Fast Five Quiz: Molecular and Biomarker Analysis in Non–Small Cell Lung Cancer (NSCLC) - Medscape - Aug 30, 2022.